These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7522747)

  • 1. [The economic evaluation of prostatic hyperthermia].
    Merliere Y; Viens-Bitker C; Houee J; Dutheil M; Abbou C
    Prog Urol; 1994; 4(4):547-54. PubMed ID: 7522747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Under what conditions is feedback microwave thermotherapy (ProstaLund Feedback Treatment) cost-effective in comparison with alpha-blockade in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms?
    Ragnarson Tennvall G; Hjelmgren J; Malmberg L
    Scand J Urol Nephrol; 2006; 40(6):495-505. PubMed ID: 17130102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of biomedical equipment repair and maintenance: results of a survey.
    Cohen T
    Med Instrum; 1982; 16(5):269-71. PubMed ID: 7176994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Local hyperthermia in benign prostatic hyperplasia].
    Bichler KH; Strohmaier WL; Flüchter SH
    Urologe A; 1991 Mar; 30(2):122-6. PubMed ID: 1711728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New microwave transurethral hyperthermia for benign prostatic hyperplasia--clinical evaluation].
    Ito T; Namiki K; Aizawa T; Ogawa M; Hokoishi F; Ohkubo Y; Miki M
    Hinyokika Kiyo; 1993 Nov; 39(11):997-1001. PubMed ID: 7505525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water-induced thermotherapy for benign prostatic hyperplasia.
    Cioanta I; Muschter R
    Tech Urol; 2000 Dec; 6(4):294-9. PubMed ID: 11108569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy.
    Manyak MJ; Ackerman SJ; Blute ML; Rein AL; Buesterien K; Sullivan EM; Tanio CP; Strauss MJ
    J Endourol; 2002 Feb; 16(1):51-6. PubMed ID: 11890452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saving money on equipment service.
    McGachey R
    J Cardiovasc Manag; 1996; 7(3):31-2. PubMed ID: 10158420
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of microwave induced hyperthermia in the treatment of BPH: the Paris public hospitals' experience.
    Abbou CC; Colombel M; Payan C; Beurton D; Viens-Bitker C; Richard F; Gibod LB; Leduc A; Jardin A; Chatelain C
    Prog Clin Biol Res; 1994; 386():449-53. PubMed ID: 7528414
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of new treatments for benign prostatic hyperplasia: results of a randomized trial comparing the short-term cost-effectiveness of transurethral interstitial laser coagulation of the prostate, transurethral microwave thermotherapy and standard transurethral resection or incision of the prostate.
    Nørby B; Nielsen HV; Frimodt-Møller PC
    Scand J Urol Nephrol; 2002; 36(4):286-95. PubMed ID: 12201922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transrectal hyperthermia for benign prostatic hyperplasia].
    Satoh Y; Okada K
    Hinyokika Kiyo; 1991 Nov; 37(11):1447-8. PubMed ID: 1722631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Localized transrectal hyperthermia. Transurethral hyperthermia and thermotherapy in the treatment of benign hyperplasia of the prostate].
    Mazo E; Krivoborodov G
    J Urol (Paris); 1996; 102(1):23-5. PubMed ID: 8763601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis.
    Gordon NS
    BJU Int; 2004 May; 93(7):1118-9. PubMed ID: 15142185
    [No Abstract]   [Full Text] [Related]  

  • 15. Annual costs of benign prostatic hyperplasia in New Zealand.
    Scott WG; Scott HM
    Pharmacoeconomics; 1993 Dec; 4(6):455-68. PubMed ID: 10151048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thermotherapy of benign prostatic hyperplasia].
    Höfner K; Krah H; Tan HK; Kuczyk M; Jonas U
    Urologe A; 1995 Jan; 34(1):16-24. PubMed ID: 7533447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Late results of local transrectal hyperthermia in patients with benign prostatic hyperplasia and its complications].
    Krivoborodov GG; Koblov NL; Malenko VP; Troshin II
    Urol Nefrol (Mosk); 1995; (6):47-8. PubMed ID: 8686127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness in the management of benign prostatic hyperplasia: Italian data.
    Di Silverio F; D'Eramo G; Flammia GP; Sciarra A; Buscarini M; Mauro M; Sciarra F
    Minerva Urol Nefrol; 1994 Jun; 46(2):93-9. PubMed ID: 7526475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of hyperthermia: nine years experience at the Radiation Therapy Department of the Turin University.
    Gabriele P; Orecchia R; Madon E; Ruo Redda MG; Sannazzari GL
    Tumori; 1994 Oct; 80(5):327-31. PubMed ID: 7839459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terazosin. A pharmacoeconomic evaluation of its use in benign prostatic hyperplasia.
    Plosker GL; Goa KL
    Pharmacoeconomics; 1997 Feb; 11(2):184-97. PubMed ID: 10165827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.